Amy Finan has led Sabin as CEO since April 2016, where she has expanded its vaccine research and development portfolio and global immunization programs.
Amy Finan has led Sabin as CEO since April 2016, where she has expanded its vaccine research and development portfolio and global immunization programs. She has spearheaded Sabin’s pivot to an R&D strategy focused on developing vaccines for disease threats with limited commercial appeal, attracting over $250 million in U.S. government funding.
Full founder directory · Investor directory · Company funding database · Fundraising library